Considering the available literature and the findings of subsequent studies, we believe that, from a clinical point of view, the regulation of Nrf2 in neuropathy is extremely important, and its pharmacological modulation by astaxanthin may contribute to more effective therapies. Here, NFE2L2 is linked to neuropathy.